Not available
Quote | Nabriva Therapeutics plc (NASDAQ:NBRV)
Last: | $1.42 |
---|---|
Change Percent: | -2.11% |
Open: | $1.45 |
Close: | $1.42 |
High: | $1.9 |
Low: | $1.35 |
Volume: | 709,759 |
Last Trade Date Time: | 07/31/2023 03:00:00 am |
News | Nabriva Therapeutics plc (NASDAQ:NBRV)
2023-07-11 03:46:29 ET Arbutus Biopharma ( NASDAQ: ABUS ) has promoted Karen Sims as Chief Medical Officer and named Christopher Naftzger as General Counsel and Chief Compliance Officer, effective immediately.. Naftzger succeeds Elizabeth Howard...
2023-05-19 08:20:29 ET Lucy Scientific Discovery ( LSDI ) +43% . Farfetch Limited ( FTCH ) +22% Q1 earnings call release Greenland Technologies Holding ( GTEC ) +14% Q1 earnings call release Nabriva Therapeutics ( NBRV ) +11% . G...
Message Board Posts | Nabriva Therapeutics plc (NASDAQ:NBRV)
Subject | By | Source | When |
---|---|---|---|
when nobody wants this...its will squeeze after they | TheFinalCD | investorshub | 09/22/2022 5:25:56 PM |
MM fake out! | subslover | investorshub | 09/22/2022 4:42:20 PM |
i dont doubt it now | TheFinalCD | investorshub | 09/22/2022 4:35:53 PM |
2.31 low is like .09cent pre-split meanwhile | TheFinalCD | investorshub | 09/22/2022 4:35:15 PM |
3.70= .14 prw-splif this was .36 yesterday on | TheFinalCD | investorshub | 09/16/2022 10:08:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Nabriva Therapeutics plc Company Name:
NBRV Stock Symbol:
NASDAQ Market:
-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations- -Company To Continue Work With Torreya Capital On Asset Monetization- DUBLIN, Ireland, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV) today announced that, after an assessment ...
- PK Data and Safety Profile Consistent with Previous Studies in Healthy Subjects – - Results Support Potential Utility of Lefamulin in Patients with Cystic Fibrosis - DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Na...
- Shifted Focus to SIVEXTRO to Enable Cost Cutting - - Cash Runway Extended into Q1 2023 - - Q3 2022 Total Revenue of $9.2 Million - - Engaged Torreya Capital As Strategic Advisor - - Conference call today at 4:30 p.m. Eastern Time - DUBLIN, Ireland, ...